Metastatic Pancreatic Adenocarcinoma Clinical Trials

107 clinical trials for Metastatic Pancreatic Adenocarcinoma across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer — RECRUITING · PHASE2
• Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene — RECRUITING · PHASE1
• A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer — RECRUITING · PHASE3
• TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma — RECRUITING · PHASE1
• BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma — RECRUITING · PHASE1
• Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations — RECRUITING · PHASE3
• iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation — RECRUITING · PHASE1
• Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate — RECRUITING · PHASE2
• Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers — RECRUITING · NA
• Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer — RECRUITING · PHASE3
• A study in patients with metastatic pancreatic ductal adenocarcinoma, where abraxane and gemcitabine chemotherapy will be administered either on the same day, or abraxane will be administered 24 hours before gemcitabine. — COMPLETED · PHASE2
• A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma — NOT_YET_RECRUITING · PHASE1
• Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations — ACTIVE_NOT_RECRUITING · PHASE2
• Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma — NOT_YET_RECRUITING · PHASE3
• Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer — COMPLETED · PHASE1
• A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread — ACTIVE_NOT_RECRUITING · PHASE2
• Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer — TERMINATED · PHASE2
• Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• BATs Treatment for Pancreatic Cancer, Phase Ib/II — COMPLETED · PHASE1
• AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
• Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• 64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
• Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer — COMPLETED · PHASE1
• FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer — COMPLETED · PHASE2
• Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma — TERMINATED · PHASE1
• Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery — ACTIVE_NOT_RECRUITING · PHASE1
• LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy — COMPLETED · PHASE1
• Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer — COMPLETED · PHASE1
• Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer — COMPLETED · PHASE1
• Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma — COMPLETED · PHASE2
• Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) — ACTIVE_NOT_RECRUITING · PHASE1
• Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer — COMPLETED · PHASE2
• Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma — COMPLETED · PHASE3
• A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE1
• Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer — COMPLETED · PHASE2
• Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients — TERMINATED · PHASE2
• FOLFIRINOX + NIS793 in Pancreatic Cancer — TERMINATED · PHASE1
• A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma — COMPLETED · PHASE1
• Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer — COMPLETED · PHASE1
• Vitamin C to Chemotherapy Related Anemia in Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE3

Refine this search